Matthew Gline is CEO of Roivant Sciences Ltd.. Currently has a direct ownership of 17.4 Million shares of ROIV, which is worth approximately $195 Million. The most recent transaction as insider was on Aug 22, 2023, when has been sold 11,015 shares (Common Shares) at a price of $10.83 per share, resulting in proceeds of $119,292. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 17.4M
1434.88% 3M change
1568.4% 12M change
Total Value Held $195 Million

Matthew Gline Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 22 2023
SELL
Other acquisition or disposition
$119,292 $10.83 p/Share
11,015 Reduced 1.05%
1,039,644 Common Shares
Aug 02 2023
SELL
Other acquisition or disposition
$138,520 $11.79 p/Share
11,749 Reduced 1.11%
1,050,659 Common Shares
Jul 27 2023
BUY
Exercise of conversion of derivative security
-
23,149 Added 2.13%
1,062,408 Common Shares
Jul 24 2023
SELL
Other acquisition or disposition
$122,494 $10.99 p/Share
11,146 Reduced 1.06%
1,039,259 Common Shares
Jun 22 2023
SELL
Other acquisition or disposition
$108,738 $10.01 p/Share
10,863 Reduced 1.02%
1,050,405 Common Shares
May 31 2023
SELL
Other acquisition or disposition
$275,117 $9.09 p/Share
30,266 Reduced 2.77%
1,061,268 Common Shares
May 27 2023
BUY
Exercise of conversion of derivative security
-
53,281 Added 4.65%
1,091,534 Common Shares
May 23 2023
SELL
Other acquisition or disposition
$181,751 $9.58 p/Share
18,972 Reduced 1.79%
1,038,253 Common Shares
Apr 20 2023
SELL
Payment of exercise price or tax liability
$170,500 $8.8 p/Share
19,375 Reduced 1.8%
1,057,225 Common Shares
Mar 23 2023
SELL
Other acquisition or disposition
$135,509 $7.3 p/Share
18,563 Reduced 1.69%
1,076,600 Common Shares
Feb 22 2023
SELL
Other acquisition or disposition
$121,990 $8.43 p/Share
14,471 Reduced 1.3%
1,095,163 Common Shares
Jan 24 2023
SELL
Other acquisition or disposition
$133,484 $8.56 p/Share
15,594 Reduced 1.39%
1,109,634 Common Shares
Dec 23 2022
SELL
Other acquisition or disposition
$137,796 $7.1 p/Share
19,408 Reduced 1.7%
1,125,228 Common Shares
Nov 20 2022
SELL
Other acquisition or disposition
$96,865 $5.0 p/Share
19,373 Reduced 1.66%
1,144,636 Common Shares
Oct 25 2022
SELL
Open market or private sale
$84,814 $4.4 p/Share
19,276 Reduced 1.63%
1,164,009 Common Shares
Sep 23 2022
SELL
Open market or private sale
$64,633 $3.07 p/Share
21,053 Reduced 1.75%
1,183,285 Common Shares
Aug 24 2022
SELL
Open market or private sale
$74,233 $3.71 p/Share
20,009 Reduced 1.63%
1,204,338 Common Shares
Jul 25 2022
SELL
Open market or private sale
$88,570 $4.33 p/Share
20,455 Reduced 1.64%
1,224,347 Common Shares
Jun 23 2022
SELL
Open market or private sale
$86,171 $4.34 p/Share
19,855 Reduced 1.57%
1,244,802 Common Shares
May 20 2022
SELL
Open market or private sale
$517,227 $3.7 p/Share
139,791 Reduced 9.95%
1,264,657 Common Shares
Apr 25 2022
SELL
Open market or private sale
$32,675 $3.84 p/Share
8,509 Reduced 0.6%
1,404,448 Common Shares
Mar 30 2022
SELL
Payment of exercise price or tax liability
$119,704 $4.74 p/Share
25,254 Reduced 1.76%
1,412,957 Common Shares
Mar 30 2022
SELL
Open market or private sale
$163,040 $4.84 p/Share
33,686 Reduced 2.29%
1,438,211 Common Shares
Mar 25 2022
SELL
Open market or private sale
$179,053 $5.06 p/Share
35,386 Reduced 2.35%
1,471,897 Common Shares
Mar 18 2022
SELL
Open market or private sale
$420,691 $5.13 p/Share
82,006 Reduced 5.16%
1,507,283 Common Shares
MG

Matthew Gline

CEO
London, X0

Track Institutional and Insider Activities on ROIV

Follow Roivant Sciences Ltd. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ROIV shares.

Notify only if

Insider Trading

Get notified when an Roivant Sciences Ltd. insider buys or sells ROIV shares.

Notify only if

News

Receive news related to Roivant Sciences Ltd.

Track Activities on ROIV